Clinical TrialsSearch results
Number of results: 508
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
- chronic hepatitis B
- CHUGAI PHARMACEUTICAL CO.LTD.
- 2007-04-26
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.
- low grade B cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 2008-06-20
Other
- Combination Therapy of Lanthanum Carbonate and Calcium Carbonate: COLC Study
- Hemodialysis patients with hyperphosphatemia
- COLC Study Research group
- 2009-04-06
Recruiting
- A Study to Compare the Efficacy and Safety of Ide-cel with LEN Maintenance Therapy Versus
LEN Maintenance Therapy Alone in Adult Participants with NDMM Who Have Suboptimal
Response After ASCT
- Multiple Myeloma
- Cook Mark
- 2023-12-24
Other
- Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial
- Outpatients who are required a combination therapy with sitting systolic blood pressure >=140 mmHg or diastolic blood pressure>=90 mmHg
- COPE Trial Group
- 2008-05-12
Recruiting
- COmbination Strategy on renal function of the benidipine or diuretics treatMent with RAS inhibitOrs in CKD hypertensive population
- Hypertensive patients with albuminuria under the treatment of the inhibitor of the renin-angiotension system (RAS)
- COSMO-CKD Study Group
- 2009-07-01
Completed
- Treatment of halitosis with photodynamic therapy
- Halitosis
- Daisuke Ekuni
- 2021-03-05
Other
- Study on Therapeutic Effects of Antiplatelet Drugs in Prevention of Occurrence and Inhibition of Progression of Diabetic Atherosclerosis
- Diabetes
- DAPC Study Steering Committee
- 2005-10-01
Recruiting
- Ivosidenib in participants with locally advanced or metastatic conventional chondrosarcoma untreated or previously treated with 1
systemic treatment regimen
- Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, 0 or 1 Regimen
- Debruyne Channa
- 2024-07-12